𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Late toxicity after treatment for testicular germ cell cancer

✍ Scribed by A. Jakob; C. Kollmannsberger; L. Kanz; C. Bokemeyer

Publisher
Springer
Year
1998
Tongue
German
Weight
377 KB
Volume
37
Category
Article
ISSN
0340-2592

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Late toxicity following curative treatme
Late toxicity following curative treatment of testicular cancer
✍ Christian Kollmannsberger; Markus Kuzcyk; F. Mayer; JΓΆrg T. Hartmann; Lothar Kan πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

Cisplatin appears to be the major cause for long-term toxicity in patients treated for testicular cancer. Long-term side effects consist mainly of nephrotoxicity, ototoxicity, and neurotoxicity as well as gonadal damage. Following standard-dose chemotherapy approximately 20% to 30% of patients will

Treatment of patients with cisplatin-ref
Treatment of patients with cisplatin-refractory testicular germ-cell cancer
✍ Carsten Bokemeyer; Christian Kollmannsberger; Andreas Harstrick; JΓΆrg Beyer; Art πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 78 KB πŸ‘ 2 views

With the use of cisplatin-based combination chemotherapy, metastatic testicular germ-cell tumors can be cured in 70% to 80% of patients. The combination of cisplatin, etoposide and bleomycine (PEB) is considered standard therapy.

Second cancer after treatment of maligna
Second cancer after treatment of malignant germ-cell tumors
✍ S. D. FossΓ₯; E. Hoff WanderΓ₯s; K. Heimdal πŸ“‚ Article πŸ“… 1994 πŸ› Springer-Verlag 🌐 English βš– 386 KB

Patients cured of a malignant germ-cell tumor are at a significantly increased relative risk (RR, 1.3-2.1) of developing a new malignancy, the most frequent second cancer being a new germ-cell cancer. The exact role of modern treatment of germ-cell malignancies as an etiological factor of a subseque